Skip to main content

COMSCORE INC

For the period ended Dec 31, 2024. Filed Mar 6, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 6, 2025

SCOR$3.12-5.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. CONSOLIDATED STATEMENTS OF CASH FLOWS

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years Ended December 31,
(In thousands)202420232022
Operating activities:
Net loss$(60,248)$(79,361)$(66,561)
Adjustments to reconcile net loss to net cash provided by operating activities:
Impairment of goodwill63,00078,20046,300
Depreciation22,08719,77816,828
Non-cash operating lease expense5,2405,4566,060
Amortization expense of finance leases3,6511,9292,364
Stock-based compensation expense3,1914,5358,178
Amortization of intangible assets3,0575,21327,096
Impairment of right-of-use and long-lived assets1,3971,502156
Change in fair value of warrant liability(669)(49)(9,802)
Deferred tax provision(841)(35)(475)
Other2,0082,2974,468
Changes in operating assets and liabilities:
Accounts receivable(1,649)4,7812,596
Prepaid expenses and other assets1,9872,185(805)
Accounts payable, accrued expenses, and other liabilities(10,570)(4,121)7,396
Contract liability and customer advances(4,739)(5,517)(1,587)
Operating lease liabilities(8,798)(7,867)(7,275)
Net cash provided by operating activities18,10428,92634,937
Investing activities:
Capitalized internal-use software costs(23,249)(22,206)(16,685)
Purchases of property and equipment(813)(1,580)(1,137)
Net cash used in investing activities(24,062)(23,786)(17,822)
Financing activities:
Proceeds from secured term loan45,000——
Proceeds from insurance financing2,118——
Payments for dividends on convertible redeemable preferred stock (1)——(15,512)
Principal payments on insurance financing(2,122)——
Principal payments on finance leases(2,852)(2,066)(2,519)
Contingent consideration payment at initial value(3,704)(1,037)—
Payments of debt issuance costs(4,551)——
Payments of line of credit(16,000)——
Other(266)(291)(101)
Net cash provided by (used in) financing activities17,623(3,394)(18,132)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(1,133)748(820)
Net increase (decrease) in cash, cash equivalents and restricted cash10,5322,494(1,837)
Cash, cash equivalents and restricted cash at beginning of period22,93620,44222,279
Cash, cash equivalents and restricted cash at end of period$33,468$22,936$20,442
As of December 31,
202420232022
Cash and cash equivalents$29,937$22,750$20,044
Restricted cash3,531186398
Total cash, cash equivalents and restricted cash$33,468$22,936$20,442
Years Ended December 31,
202420232022
Supplemental cash flow disclosures:
Interest paid$1,211$1,542$652
Income taxes paid, net of refunds1,3052,1081,804
Operating cash flows from operating leases11,08110,92210,364
Operating cash flows from finance leases712244338
Supplemental non-cash activities:
Issuance of convertible redeemable preferred stock (related parties) (1) (2)32,771——
Convertible redeemable preferred stock dividends accrued but not yet paid (1)8,96216,2707,863
Right-of-use assets obtained in exchange for finance lease liabilities7,8613,1951,106
Settlement of restricted stock unit liability1,8952,7621,718
Modification of operating right-of-use assets1,216292—
Change in accounts payable and accrued expenses related to capital expenditures6531,1301,162
Accrued debt issuance costs559——
Right-of-use assets obtained in exchange for new operating lease liabilities—1,211908

(1) Transactions for these line items were exclusively with related parties (refer to Footnote 4, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit), and Footnote 13, Related Party Transactions, of the Notes to Consolidated Financial Statements for additional information).

(2) The convertible redeemable preferred stock issued in 2024 was initially recognized at fair value. The Company recorded the initial fair value, net of issuance costs, of $19.6 million within mezzanine equity and the remaining $13.0 million within additional paid-in capital on the Consolidated Balance Sheets. Refer to Footnote 4, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit), of the Notes to Consolidated Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.